Michael Berger
@mfberger.bsky.social
Cancer scientist studying clinical cancer genomics and computational biology. Comments and opinions are my own.
Reposted by Michael Berger
Congratulations to the MSK-IMPACT team MSK for receiving the @theaacr.bsky.social Team Science Award.
The team is recognized for its pivotal advances in clinical genomic sequencing that have transformed oncology practice, clinical trials, and cancer discovery research. Learn more: bit.ly/4jJMaOu
The team is recognized for its pivotal advances in clinical genomic sequencing that have transformed oncology practice, clinical trials, and cancer discovery research. Learn more: bit.ly/4jJMaOu
April 27, 2025 at 1:34 PM
Congratulations to the MSK-IMPACT team MSK for receiving the @theaacr.bsky.social Team Science Award.
The team is recognized for its pivotal advances in clinical genomic sequencing that have transformed oncology practice, clinical trials, and cancer discovery research. Learn more: bit.ly/4jJMaOu
The team is recognized for its pivotal advances in clinical genomic sequencing that have transformed oncology practice, clinical trials, and cancer discovery research. Learn more: bit.ly/4jJMaOu
Reposted by Michael Berger
Dr. Michael Berger, Dr. David Solit, Dr. Marc Ladanyi, & the MSK-Impact team accept the @theaacr.bsky.social Team Science Award for developing & implementing a groundbreaking next-gen sequencing platform which has enabled the comprehensive molecular characterization of over 125,000 tumors. #AACR25
April 27, 2025 at 3:20 PM
Dr. Michael Berger, Dr. David Solit, Dr. Marc Ladanyi, & the MSK-Impact team accept the @theaacr.bsky.social Team Science Award for developing & implementing a groundbreaking next-gen sequencing platform which has enabled the comprehensive molecular characterization of over 125,000 tumors. #AACR25